About Us
Our team brings together extensive experience in drug discovery and development. With a proven track record of delivering best-in-class medicines, we combine deep disease biology expertise with cutting-edge technologies. The team has successfully advanced both small and large molecule programmes across various therapeutic areas
Meet the Team

Pierre Raboisson
Chief Executive Officer Chief Scientific Officer Co-founder

Marie De Vulder
Chief Legal Officer Co-founder
Guy Peeters
Chief Financial Officer Co-founder

John-Paul Gallivan
Head of Development Co-founder

Lieve Lammens
Toxicology

Tom Govaerts
Chemistry, Manufacturing and Controls

Gert De Beckker
Head of Regulatory

Fabrice Kolb
Head of Immunology Co-founder
Pieter Peeters
Operating & Technology Officer Co-founder

François Gonzalvez
Co-founder

Sandrine Vendeville
Co-founder
Joost Kolkman
Co-founder
Backed by Leading Investors





